DIA Trial Master File Reference Model

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

© 2011 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Medsafe – GMP update / release for supply / communicating quality issues Derek Fitzgerald Manager, Compliance Management 11 July 2013 RACI Pharmaceutical.
Management Through Systems Vicki Latter Biomedicine Research & Development Unit University College London.
OASIS Electronic Trial Master File Standard Technical Committee Meeting Agenda May 19, :00 – 10:00 AM PDT.
Cheryl McCarthy Manager, Quality Assurance MBC Session October 3, 2008 GCP Compliance in our Vendors.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
©2014 Factorytalk Co., Ltd. Proprietary and Confidential eCTD Specification 17 July 2014.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
United Nations Expert Group Meeting on Revising the Principles and Recommendations for Population and Housing Censuses New York, 29 October – 1 November.
Knowledge Update Clinical documentation: from preclinical studies to drug registration Split, 12 September 2008.
RPS WG Update March 2015 Open Stakeholder Session Nancy Shadeed Health Canada.
Bay Area CDISC Implmentation Network – July 13, 2009 How a New CDISC Domain is Made Carey Smoak Team Leader CDISC SDTM Device Team.
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Web Development Process Description
Value Engineering at FHWA
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Clinical Trials Market in Russia 17 October 2008 ROTOBO - ACTO.
Contents Integrating clinical trial data Working with CROs
Trial Master File Reference Model Supported by the DIA Document and Records Management Special Interest Area Committee Karen Redding, Co-Chair.
PRODUCT TRANSFER.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
Trial Master File Reference Model Supported by the DIA Document and Records Management Special Interest Area Committee Published: 22 August 2012.
IRISS Lifecycle Group Joe Cipollina – Pfizer Ted Hanebach – canreg Shy Kumar – Datafarm Inc. Alastair Nixon – GlaxoSmithKline Kevin Wing - eCTDConsultancy.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
The Road to Version 3 27 th October  Created and maintained through a group of DIA (Drug Information Association) volunteers ◦ ~350 contributors.
Regulated Product Submission HL7 Update Wednesday January 10 th, 2007 Jason Rock
Overview of FDA's Regulatory Framework for PET Drugs
Regional Seminar on Promotion and Utilization of Census Results and on the Revision on the United Nations Principles and Recommendations for Population.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
CTD Dossier Preparation K. Srikantha Reddy Sr
Trial Master File Reference Model
Aim: “to support the enhancement and implementation of the standards needed for the modernisation of statistical production and services”
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
ESSRT In-Process Review September 10, Agenda 1.Work Completed Till Date 2.Scope of future activities and deliverables 2.
Trial Master Files – the De-Centralised Communication Challenge Karen Roy.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.
Shared Services SA SA TENDERS AND CONTRACTS Shared Services SA Presented by Glenn Dawson, Principal Consultant Electronic Procurement Services.
1 DIA SIAC TMF Reference Model Lisa Mulcahy Karen Roy.
© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.
Regulated Product Submission Eileen M. Girten, MS i3 Statprobe 1DIA Education SIAC.
GCP (GOOD CLINICAL PRACTISE)
Business Considerations in eTMF Implementation Karen Roy Phlexglobal Ltd.
Paper Destruction Team Full Team Meeting 9 April 2013.
Responsibilities of Sponsor, Investigator and Monitor
Process-based Metadata From a DIA Presentation: eTMF – Migrating from Paper Trial Master Files to Electronic Eldin Rammell, Managing Director, Rammell.
Paper Destruction - Legal Topic Team
New legislation impacting IMP
Responsibilities of Sponsor, Investigator and Monitor
<workgroup name>
CTD Content Management
The Information Professional’s Role in Product Safety
Quality Subgroup Output
Modernization of ICH E8 Sholeh Ehdaivand, President and CEO
PREPARATION FOR GMP INSPECTION
DIA SIAC TMF Reference Model
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
OASIS Electronic Trial Master File Standard Technical Committee Meeting Agenda June 20, :00 – 9:30 AM PDT.
How was CPT Developed and What Does it Look Like?


Easy TMF Introduction & Demo for QED Clinical Services
Fundamentals of Electronic Submissions and eCTD


S A Overarching SOPs Funding Secured Training Records
Presentation transcript:

DIA Trial Master File Reference Model

EDM Reference Model DIA Document and Records Management Special Interest Area Community initiative since 2008 Standardization effort for the industry with eCTD backbone Version 1 launched in 2008, update in the works Extensions of the model are in development Interconnects with TMF Reference Model in trial related submission documentation Ensure mapping of taxonomy and alignment of metadata

Why a TMF Reference Model? ICH GCP Section 8.2 – 8.4 “The minimum list of essential documents that has been developed.....” ICH GCP does NOT provide a comprehensive contents list for the TMF Examples of missing documentation: Electronic systems Data management and statistical methodology Safety monitoring

The Trial Master File The Trial Master File Supporting files e.g. computer SDLC files; GMP manufacturing files; vendor selection files Other business records Minimum list of essential documents, as defined by ICH GCP, Chapter 8 Other trial-related records that “permit evaluation of the conduct of the trial and quality of data produced” Usually considered outside the scope of the TMF The Trial Master File

TMF Reference Model Goals Standard contents Industry opinion on what is kept in a TMF Standard naming Based off the ICH E6 Section 8 terminology and industry accepted terminology Standard structure It doesn’t have to be folder-based or departmentalized like in a paper system Standard metadata If TMF is an EDMS, what would be the basics – at system and artifact level? This slide gives an high-level description of how we currently file TMF documents 5

1.5 years of Accomplishments Dec08-Feb09 DIA EDM meetings to recruit team members Mar09 Inaugural meeting and charter created May09 TMF split into zones, Leads and members organized Aug09 First pass at TMF contents (artifacts) and naming Sep09 Feedback from TMF reference model members and extended review team Dec 2008 – Feb 2009 – DIA EDM meetings to talk up the topic and recruit team March 2009 – May 2009 - Aug 2009 – Sept 2009 – Dec 2009 – Mar10 Artifacts narrowed, definitions added, requirement level and metadata requirements in refinement Jun10 Version 1.0 release 6

How Work on the Model is Organized? 11 Zones and 222 Artifacts Trial Management Central Trial Documents Regulatory IRB/IEC and other Approvals Site Management IP and Trial Supplies Safety Reporting Centralized Testing Third Parties Data Management Statistics 7

Who’s Been Involved? 139 members on team 98 Companies 55% US, 45% EU 98 Companies Pharma CRO Vendor Regulatory agency review MHRA FDA 8

TMF Reference Model Version 1.0 Overview

Artifact Definition

Core / Recommended, ICH & EDM

Metadata

Overall Model

Using the TMF Reference Model for paper

Future Plans Linked in group (TMF Reference Model) Continued connection with industry representatives Coordinated feedback on the utilization of the model by sponsors, CROs, and vendors Version 1.1 expected by Dec 2010 / early 2011 Technical guide to the model Version 2.0 of model expected by June 2011 may include: Device Studies Early phase studies Investigator Initiated Studies Regional expansive view